Trials / Completed
CompletedNCT04407299
COVID-19 Impact on Rheumatic Patients
Impact of COVID-19 Pandemic on Attitude, Behaviour and Mental Health of Patients With Rheumatic Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 360 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- —
Summary
A study to assess the impact of coronavirus disease 2019 (COVID-19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individuals.
Detailed description
To assess the impact of coronavirus disease 2019 (COVID19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individual. This is cross-sectional survey, 360 participants were included and divided into cases group composed of 180 patients with rheumatic diseases and control group composed of 180 healthy people. Data were collected via a self-administered structured questionnaire (Google form) which was sent to participants via social networks and emails to different rheumatic patients and healthy individuals. Mental health was measured by the five-item Brief Symptom Rating Scale (BSRS-5). Conclusion: Mental health should be addressed in the same manner we deal with the infectious disease itself, being of no less importance. It is essential for mental health professionals provide psychological support to vulnerable populations, including the infected and chronically ill patients and their families, individuals, communities and health care workers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | self-administered structured questionnaire | It was designed as a self-administered questionnaire with closed questions (yes/no questions, rating scale and multiple choice questions) and some open ended questions. |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2020-05-10
- Completion
- 2020-05-20
- First posted
- 2020-05-29
- Last updated
- 2020-07-15
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04407299. Inclusion in this directory is not an endorsement.